Fredrik Netzel
Corporate Officer/Principal at OLINK HOLDING AB
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jon Aron Olof Heimer | M | 57 | 4 years | |
| Nicolas Roelofs | M | 66 | 6 years | |
| Robert Schueren | M | 62 | 2 years | |
| Tommi Markus Unkuri | M | 44 | 5 years | |
| Mary Reumuth | F | 48 | 2 years | |
| Rickard El Tarzi | M | - | 5 years | |
| Solange Bullukian | F | 59 | 3 years | |
| Jon Hindar | M | 68 | 3 years | |
| Carl Raimond | M | 53 | 4 years | |
| Johan Lund | M | 67 | 4 years | |
| Ida Grundberg | M | 41 | 5 years | |
| Bruno Rossi | M | - | 1 years | |
| Linda Ramirez-Eaves | F | 52 | 5 years | |
| Mark Beveridge | M | 46 | 9 years | |
| Oskar Hjelm | M | 39 | 4 years | |
| Gregory Moore | M | 59 | 1 years | |
| Gunilla Wengström | F | 62 | 5 years | |
| Annica Magnusson | F | 61 | 5 years | |
| Anna Maria Marsell | F | 46 | 2 years | |
| Johan Holmner | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas Lennart Eklund | M | 57 | 4 years | |
| Mats Gunnar Pettersson | M | 78 | 6 years | |
| Torbjörn Wärnheim | M | 66 | 7 years | |
| Thomas Bjerregaard Thomsen | M | 54 | 4 years | |
| Torbjörn Mattias Koivisto | M | 55 | 9 years | |
| Mattias Klintemar | M | 57 | - | |
| Geert Cauwenbergh | M | 70 | 7 years | |
| Tina Nova | M | 70 | 1 years | |
| Wenche Nelly A. Rolfsen Sandsborg | M | 72 | 7 years | |
| Gustavo Salem | M | 60 | 3 years | |
| Solange Glaize | F | 60 | - | |
| Andrew B. Hochman | M | 57 | - | |
| Jacques Näsström | M | 65 |
Q-Med AB
 Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | 4 years |
| Peter Michael Rothschild | M | 74 | - | |
| Johanna Isander | F | 42 | - | |
| Sarah Hellerfelt | F | 42 | 2 years | |
| Shaw Sorooshian | M | 60 | 2 years | |
| Ingela Berglund | F | - | - | |
| Lena Båvegård | F | 57 |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | 6 years |
| Ulf Sven Ivar Mattsson | M | 60 |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | - |
| Maria Carell | F | 51 |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | 1 years |
| Tommy Gullbo | M | 60 |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | - |
| Erik Sundquist | M | 54 |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | 1 years |
| Alexander Kotsinas | M | 57 |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | 3 years |
| Sara Catherine Brandt | F | 61 | 2 years | |
| George Aitken-Davies | M | 46 | 2 years | |
| Anna Yvonne Monica Malm Bernsten | F | 63 | 1 years | |
| Martin Ingman | M | 62 | 9 years | |
| Jeff Vernimb | M | 61 | 2 years | |
| Gunilla Lundmark | F | 61 |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | - |
| Ernst Åke Bertil Karlmark | M | 86 | 6 years | |
| Kjell Rensfeldt | M | 67 | 11 years | |
| Per Sundqvist | M | 58 |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | 1 years |
| Carin Dahlquist | F | - |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | 1 years |
| Bertil Hult | M | - |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | 12 years |
| Lena Pereswetoff Morath | M | 64 | - | |
| Tomas Nicolin | M | 70 |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | - |
| Kristina Persson | F | 79 |
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 58 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Fredrik Netzel
- Personal Network
